Journal
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY
Volume 16, Issue 3, Pages 186-192Publisher
AVES
DOI: 10.4261/1305-3825.DIR.2537-08.1
Keywords
pathologic angiogenesis; angiogenic inhibitors; magnetic resonance imaging
Funding
- Intramural NIH HHS [Z01 BC010714-03] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [ZIABC010714, ZIABC010655] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Angiogenesis is a key step in the pathophysiology of tumor growth and metastatic spread. Recently, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has emerged as a method for assessing angiogenesis both during the initial diagnosis and for follow up of anti-angiogenic therapies. In this review, we discuss the technical aspects of implementing DCE-MRI in clinical practice with emphasis on acquisition methods and analytic techniques.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
